← FDA Drug Approvals (Drugs@FDA)
SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2024-03-19
Drug application
- FDA Application #
ANDA206431- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE
- Generic name
- SODIUM SULFATE ANHYDROUS, POTASSIUM SULFATE, AND MAGNESIUM SULFATE
- Active ingredients
- MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE
- Dosage form
- SOLUTION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- TARO
- Manufacturer
- Sun Pharmaceutical Industries, Inc.
- First approval
- 2024-03-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown